Header Logo

Connection

GEORGE R BLUMENSCHEIN to Placebos

Back to Details
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about Placebos.
GEORGE R BLUMENSCHEIN
Connection Strength
0.020
Placebos
  1. Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC). Invest New Drugs. 2011 Jun; 29(3):499-505.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.